Business Description
Almirall SA
NAICS : 325412
ISIN : ES0157097017
Share Class Description:
FRA:E2Z: Ordinary SharesCompare
Compare
Traded in other countries / regions
ALM.Spain0O9B.UKE2Z.GermanyALM.AustriaLBTSF.USA IPO Date
2007-06-26Description
Almirall SA is a Spain-based company engaged in development, manufacture, and selling pharmaceutical products across a range of therapeutic areas. It aims to provide treatments in areas of dermatology, respiratory, gastrointestinal, central nervous systems, and other specialties. The company operates in five segments: Sales of its own network, sales of licensees, Research and developments, Sales of Therapeutic dermatological products in the U.S., and Corporate management. The medical dermatology business in the Europe is the key driver of the company's operation. Other than Europe, the company also operates in the Americas, Asia, Africa, and Oceania through subsidiaries.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.96 | |||||
| Equity-to-Asset | 0.62 | |||||
| Debt-to-Equity | 0.28 | |||||
| Debt-to-EBITDA | 3.2 | |||||
| Interest Coverage | 5.97 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | 1.94 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 0.2 | |||||
| 3-Year EBITDA Growth Rate | -21.3 | |||||
| 3-Year Book Growth Rate | -1.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 14.63 | |||||
| Future 3-5Y Total Revenue Growth Rate | 9.4 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 70.67 | |||||
| 9-Day RSI | 67.59 | |||||
| 14-Day RSI | 63.02 | |||||
| 6-1 Month Momentum % | -5.55 | |||||
| 12-1 Month Momentum % | -11.06 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.05 | |||||
| Quick Ratio | 1.57 | |||||
| Cash Ratio | 1.11 | |||||
| Days Inventory | 493.49 | |||||
| Days Sales Outstanding | 95.92 | |||||
| Days Payable | 631.24 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.18 | |||||
| Dividend Payout Ratio | 6.34 | |||||
| 3-Year Dividend Growth Rate | -2.4 | |||||
| Forward Dividend Yield % | 2.18 | |||||
| 5-Year Yield-on-Cost % | 2.1 | |||||
| 3-Year Average Share Buyback Ratio | -5.5 | |||||
| Shareholder Yield % | 6.74 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 77.23 | |||||
| Operating Margin % | 8.45 | |||||
| Net Margin % | 2.57 | |||||
| FCF Margin % | -0.86 | |||||
| ROE % | 0.85 | |||||
| ROA % | 0.53 | |||||
| ROIC % | 0.95 | |||||
| ROC (Joel Greenblatt) % | 18.21 | |||||
| ROCE % | 1.81 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 17.54 | |||||
| PE Ratio without NRI | 295.52 | |||||
| Shiller PE Ratio | 22.99 | |||||
| PS Ratio | 3.57 | |||||
| PB Ratio | 1.22 | |||||
| Price-to-Tangible-Book | 9.16 | |||||
| Price-to-Operating-Cash-Flow | 31.28 | |||||
| EV-to-EBIT | 51.41 | |||||
| EV-to-Forward-EBIT | 11.13 | |||||
| EV-to-EBITDA | 14.49 | |||||
| EV-to-Forward-EBITDA | 9.73 | |||||
| EV-to-Revenue | 3.91 | |||||
| EV-to-Forward-Revenue | 1.9 | |||||
| EV-to-FCF | -450.94 | |||||
| Price-to-Projected-FCF | 1.88 | |||||
| Price-to-Median-PS-Value | 1.19 | |||||
| Price-to-Graham-Number | 11.09 | |||||
| Earnings Yield (Greenblatt) % | 1.94 | |||||
| FCF Yield % | -0.22 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Almirall SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 467.233 | ||
| EPS (TTM) (€) | -0.067 | ||
| Beta | 0.53 | ||
| Volatility % | 25.55 | ||
| 14-Day RSI | 63.02 | ||
| 14-Day ATR (€) | 0.073725 | ||
| 20-Day SMA (€) | 8.15975 | ||
| 12-1 Month Momentum % | -11.06 | ||
| 52-Week Range (€) | 7.425 - 9.79 | ||
| Shares Outstanding (Mil) | 209.18 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Almirall SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Almirall SA Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Almirall SA Frequently Asked Questions
What is Almirall SA(FRA:E2Z)'s stock price today?
The current price of FRA:E2Z is €8.53. The 52 week high of FRA:E2Z is €9.79 and 52 week low is €7.43.
When is next earnings date of Almirall SA(FRA:E2Z)?
The next earnings date of Almirall SA(FRA:E2Z) is 2024-05-31 Est..
Does Almirall SA(FRA:E2Z) pay dividends? If so, how much?
The Dividend Yield %  of Almirall SA(FRA:E2Z) is 2.18% (As of Today), Highest Dividend Payout Ratio of Almirall SA(FRA:E2Z) was 6.34. The lowest was 0.32. And the median was 0.46. The  Forward Dividend Yield % of Almirall SA(FRA:E2Z) is 2.18%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers